1.56 score from hupso.pl for:
one-ventures.com.au



HTML Content


Title oneventures - investment and venture capital

Length: 49, Words: 6
Description pusty

Length: 0, Words: 0
Keywords pusty
Robots index,follow
Charset UTF-8
Og Meta - Title pusty
Og Meta - Description pusty
Og Meta - Site name pusty
Tytuł powinien zawierać pomiędzy 10 a 70 znaków (ze spacjami), a mniej niż 12 słów w długości.
Meta opis powinien zawierać pomiędzy 50 a 160 znaków (łącznie ze spacjami), a mniej niż 24 słów w długości.
Kodowanie znaków powinny być określone , UTF-8 jest chyba najlepszy zestaw znaków, aby przejść z powodu UTF-8 jest bardziej międzynarodowy kodowaniem.
Otwarte obiekty wykresu powinny być obecne w stronie internetowej (więcej informacji na temat protokołu OpenGraph: http://ogp.me/)

SEO Content

Words/Characters 1456
Text/HTML 15.57 %
Headings H1 0
H2 13
H3 17
H4 4
H5 0
H6 0
H1
H2
about oneventures
the oneventures team
funds
investment portfolio
awards and accolades
latest news
find-me technologies strengthens the board in readiness for rapid growth
find-me technologies strengthens the board in readiness for rapid growth
oneventures awarded biomedical translation $170m funding
data published in cancer medicine demostrate clinical genomics' blood test for colorectal cancer recurrence is two-fold more sensitive than cea test
clinical genomics strenghtens it's leadership team with multiple key appointments
media release - oneventures appoints dr graeme wald to life sciences investment team
contact us
H3
connect with us
board of directors
innovation fund (fund i)
innovation and growth fund (fund ii)
information for stakeholders interested in the significant investment visa (siv) programme
oneventures innovation fund (fund i)
oneventures innovation and growth fund (fund ii)
other investments
smart sparrow
vaxxas
incoming media
incoming media
smart sparrow
vaxxas
for entrepreneurs
for investors
general enquiries
H4 see all awards
see all news
sydney
brisbane
H5
H6
strong
dr michelle deaker
dr paul kelly
anne-marie birkill
graeme wald
dr amir zalcenstein
james mcgrath
helen liu
jelly jakob
jen ball
walter lewin
simon moore
roger massy-greene
the oneventures innovation fund
the oneventures innovation and growth fund
application for funding
here
about find-me technologies carers wearable:
website   
series a and beyond
b
i
em
Bolds strong 19
b 0
i 0
em 0
Zawartość strony internetowej powinno zawierać więcej niż 250 słów, z stopa tekst / kod jest wyższy niż 20%.
Pozycji używać znaczników (h1, h2, h3, ...), aby określić temat sekcji lub ustępów na stronie, ale zwykle, użyj mniej niż 6 dla każdego tagu pozycje zachować swoją stronę zwięzły.
Styl używać silnych i kursywy znaczniki podkreślić swoje słowa kluczowe swojej stronie, ale nie nadużywać (mniej niż 16 silnych tagi i 16 znaczników kursywy)

Statystyki strony

twitter:title pusty
twitter:description pusty
google+ itemprop=name pusty
Pliki zewnętrzne 14
Pliki CSS 1
Pliki javascript 13
Plik należy zmniejszyć całkowite odwołanie plików (CSS + JavaScript) do 7-8 maksymalnie.

Linki wewnętrzne i zewnętrzne

Linki 89
Linki wewnętrzne 81
Linki zewnętrzne 8
Linki bez atrybutu Title 24
Linki z atrybutem NOFOLLOW 0
Linki - Użyj atrybutu tytuł dla każdego łącza. Nofollow link jest link, który nie pozwala wyszukiwarkom boty zrealizują są odnośniki no follow. Należy zwracać uwagę na ich użytkowania

Linki wewnętrzne

about us #aboutus
team #team
funds #funds
portfolio #portfolio
awards #awards
news #news
contact us #contactus
about us #aboutus
team #team
funds #funds
portfolio #portfolio
awards #awards
news #news
contact us #contactus
- /team/#mdeaker
- /team/#pkelly
- /team/#abirkill
- /team/#gwald
- /team/#azalcenstein
- /team/#jmcgrath
- /team/#hliu
- /team/#jjakob
- /team/
- /team/#wlewin
- /team/#smoore
- /team/#rmgreene
application for funding /contact-us/
here /contact-us/#contactus-siv
- /portfolio/#hatchtech
- /portfolio/#vaxxas
- /portfolio/#smartsparrow
- /portfolio/#palomamobile
- /portfolio/#buildingiq
- /portfolio/#incomingmedia
- /portfolio/#charmhealth
- /portfolio/#peak3
- /portfolio/#beasy
- /portfolio/#findme
- /portfolio/#clinicalgenomics
- /portfolio/#vaxxas-fundii
- /portfolio/#employmenthero
- /portfolio/#agamatrix
- /awards/
smart sparrow /portfolio/#smartsparrow
finalist in the bill and melinda gates foundation $20m digital courseware challenge /news-story/2014/10/02/smart-sparrow-wins-gates-e-learning-grant/
vaxxas /portfolio/#vaxxas
world economic forum technology pioneer 2015 /news-story/2014/08/28/vaxxas-selected-as-world-economic-forum-technology-pioneer-2015/
incoming media /portfolio/#incomingmedia
warner bros announces 2014 media camp class /news-story/2014/06/02/warner-bros.-entertainment-announces-2014-media-camp-class/
incoming media /portfolio/#incomingmedia
spiffy award nominee 2013 - ground breaking award for engineering /news-story/2013/07/24/2013-spiffy-award-nominees-announced---nominee-roster-catalogs-the-telecom-startup-watch-list/
smart sparrow /portfolio/#smartsparrow
vaxxas /portfolio/#vaxxas
see all awards /awards/
find-me technologies strengthens the board in readiness for rapid growth news-story/2017/02/20/find-me-technologies-strengthens-the-board-in-readiness-for-rapid-growth
full story news-story/2017/02/20/find-me-technologies-strengthens-the-board-in-readiness-for-rapid-growth
find-me technologies strengthens the board in readiness for rapid growth news-story/2017/02/20/find-me-technologies-strengthens-the-board-in-readiness-for-rapid-growth
full story news-story/2017/02/20/find-me-technologies-strengthens-the-board-in-readiness-for-rapid-growth
oneventures awarded biomedical translation $170m funding news-story/2016/12/14/oneventures-awarded-biomedical-translation-$170m-funding
full story news-story/2016/12/14/oneventures-awarded-biomedical-translation-$170m-funding
data published in cancer medicine demostrate clinical genomics' blood test for colorectal cancer recurrence is two-fold more sensitive than cea test news-story/2016/10/19/data-published-in-cancer-medicine-demostrate-clinical-genomics'-blood-test-for-colorectal-cancer-recurrence-is-two-fold-more-sensitive-than-cea-test
full story news-story/2016/10/19/data-published-in-cancer-medicine-demostrate-clinical-genomics'-blood-test-for-colorectal-cancer-recurrence-is-two-fold-more-sensitive-than-cea-test
clinical genomics strenghtens it's leadership team with multiple key appointments news-story/2016/10/19/clinical-genomics-strenghtens-it's-leadership-team-with-multiple-key-appointments
full story news-story/2016/10/19/clinical-genomics-strenghtens-it's-leadership-team-with-multiple-key-appointments
media release - oneventures appoints dr graeme wald to life sciences investment team news-story/2016/09/01/media-release---oneventures-appoints-dr-graeme-wald-to-life-sciences-investment-team
full story news-story/2016/09/01/media-release---oneventures-appoints-dr-graeme-wald-to-life-sciences-investment-team
see all news /news/
entrepreneurs@one-ventures.com mailto:entrepreneurs@one-ventures.com
back to the top #pagetop
disclaimer /disclaimer/
contact us /contact-us/

Linki zewnętrzne

- http://sb.co/programs/australia/
- http://headsoverheels.com.au/
- http://www.ilabaccelerator.com/
- https://investor.one-ventures.com/default.aspx
- http://linkedin.com/groups/oneventures-4458377?goback=.gan_4458377
global impact learning awards 2013 (silver) http://www.one-ventures.com.au/news-story/2013/07/18/smart-sparrow-wins-silver-at-learning-impact-2013-san-diego/
biospectrum emerging company of the year 2012 http://www.vaxxas.com/news/vaxxas-recognised-as-2013-biospectrum-asia-pacific-emerging-company-of-the-year/
www.carerswatch.com.au http://www.carerswatch.com.au

Zdjęcia

Zdjęcia 33
Zdjęcia bez atrybutu ALT 0
Zdjęcia bez atrybutu TITLE 6
Korzystanie Obraz ALT i TITLE atrybutu dla każdego obrazu.

Zdjęcia bez atrybutu TITLE

/images/default-source/oneventures_2.0/springboard_logo_120x56.jpg?sfvrsn=0
/images/default-source/oneventures_2.0/heads-over-heels_logo_90x56.jpg?sfvrsn=0
/images/default-source/oneventures_2.0/ilab_logo_80x56.jpg?sfvrsn=0
/images/portfolio-images/linkedin-monochrome.jpg?sfvrsn=0
/images/default-source/oneventures_2.0/team_wlewin_201609_203x237.jpg?sfvrsn=0
/images/default-source/oneventures_2.0/team_rmgreene_201609_203x237.jpg?sfvrsn=0

Zdjęcia bez atrybutu ALT

empty

Ranking:


Alexa Traffic
Daily Global Rank Trend
Daily Reach (Percent)









Majestic SEO











Text on page:

about us team funds portfolio awards news contact us about us team funds portfolio awards news contact us oneventures is a venture capital firm headquartered in sydney, australia that provides human and investment capital into high growth companies with a particular focus on transformative technologies. the firm is particularly focused on opportunities originating in australia which are poised to expand into the established and emerging global markets. all of our partners have founded, built and exited high-growth businesses. our goal is to be the leading australian venture capital company. proudly supporting connect with us about oneventures oneventures invests in technology companies that serve or disrupt large high growth global markets. the firm has $170m in funds under management recently launching its new innovation and growth fund ii which is focused on growth and expansion stage technology companies. oneventures is managed by a team of partners with a skill-set and track record ideally suited to collaboration with entrepreneurial management teams to foster growth and create value: a unique blend of highly successful entrepreneurs, technology business founders and corporate executives with a strong scientific pedigree, extensive off-shore experience and networks. the oneventures team is committed to deliver investor returns by applying this expertise to select portfolio companies with significant potential then accelerating their performance. afsl oneventures management pty ltd is a designate under oneventures nominees pty ltd's afsl (licence no: 462825) issued by the australian securities and investments commissions, authorising the manager to provide such financial services as the manager provides during the course of its duties as manager of the fund. the oneventures team all partners have many years of c-level, board and investment experience. coupled with this is a track record of identifying investment opportunities in global markets with strong international business backgrounds and networks. the oneventures investment team has 7 technology related higher degrees. dr michelle deaker managing partner dr paul kelly managing partner anne-marie birkill managing partner graeme wald principal dr amir zalcenstein investment manager, healthcare james mcgrath investment analyst helen liu chief financial officer jelly jakob accounts jen ball office manager member name title board of directors walter lewin oneventures board of directors simon moore oneventures board of directors roger massy-greene oneventures board of directors funds innovation fund (fund i) the oneventures innovation fund is a $40m venture capital fund formed as an early stage venture capital limited partnership. this fund was launched in 2010 with the commonwealth government committing $20m from its iif programme and this funding matched by high net-worth wholesale investors. innovation and growth fund (fund ii) the oneventures innovation and growth fund was launched in march 2014 with a target of $100m and reached that target in december 2015. fund ii is an early stage venture capital limited partnership backed entirely by australian high net-worth wholesale investors. focusing on later stage (series b and beyond) investments while still maintaining some investment activity in the earlier stage investments, fund ii is now screening investment opportunities where the experience of the oneventures management team can be leveraged to accelerate value creation and company success. we are currently looking for truly transformative companies to join our portfolio of innovative companies, if you think your company has what it takes, read our application for funding page and submit your application now. information for stakeholders interested in the significant investment visa (siv) programme information for stakeholders interested in the significant investment visa programme can be found here. investment portfolio oneventures innovation fund (fund i) oneventures innovation and growth fund (fund ii) other investments awards and accolades oneventures innovation fund (fund i) other investments smart sparrow september 30, 2014 finalist in the bill and melinda gates foundation $20m digital courseware challenge vaxxas august 26, 2014 world economic forum technology pioneer 2015 incoming media may 29, 2014 warner bros announces 2014 media camp class incoming media july 15, 2013 spiffy award nominee 2013 - ground breaking award for engineering smart sparrow may 2, 2013 global impact learning awards 2013 (silver) vaxxas march 18, 2013 biospectrum emerging company of the year 2012 see all awards latest news find-me technologies strengthens the board in readiness for rapid growth by oneventures administrator | feb 20, 2017 find-me technologies, the creator of a wearable device to assist the elderly and those diagnosed with dementia, announced that it is preparing for rapid growth by strengthening the board with the appointment of global strategist adam kossak. adam kossak is an experienced senior executive, lawyer and medical doctor with more than20 years’ experience with some of the world’s leading technology companies. adam possesses advanced degrees in law (jd), business (mba) and medicine (mbbs honours). adam is a natural problem solver and consensus builder possessing the ability to identify root causes and apply win-win solutions. to date adam has completed more than 50 business acquisitions and disposals in both legal and commercial capacities. adam said, “i am honoured to join the board of directors of find-me. i look forward to working with fellow directors and management to help guide this innovative and exciting company to help improve the lives and safety of those suffering with dementia.” chair of the board, anne-marie birkill said, “adam brings extensive legal, commercial and healthcare sector experience to the board of find-me. he has held senior management roles at a number of significant australian healthcare sector companies including trakhealth and isoft and will provide crucial strategic input and support to the find-me team. we are delighted to welcome him to the board.” about find-me technologies carers wearable: the new find-me carers wearable is a bespoke product designed around the meeting the needs of those diagnosed with dementia, and the elderly wishing to live independently longer. the carers wearable can receive incoming calls, from any landline or mobile phone, has a global positioning system that can monitor the location of the wearer and an alert button that can be put through to a specialist 24/7 monitoring and response centre. the find-me carers wearable, can be worn on the wrist and not only tells the time, but also incorporates the capabilities of a mobile phone, a panic alert (with two-way voice communication), a tracking system, a fall sensor, and is water resistant so it can be worn in the shower or rain. personal emergency alarms have been large and normally limited to working around the home. the carers wearable will work anywhere there is mobile phone coverage (including telstra nextg) and is 3g compatible. website www.carerswatch.com.au full story find-me technologies strengthens the board in readiness for rapid growth feb 20, 2017 full story oneventures awarded biomedical translation $170m funding dec 14, 2016 full story data published in cancer medicine demostrate clinical genomics' blood test for colorectal cancer recurrence is two-fold more sensitive than cea test oct 19, 2016 full story clinical genomics strenghtens it's leadership team with multiple key appointments oct 19, 2016 full story media release - oneventures appoints dr graeme wald to life sciences investment team sep 01, 2016 full story see all news contact us for entrepreneurs we are now screening companies for oneventures fund ii which is a series a and beyond growth fund focusing on the technology sector. to qualify for funding, your company should meet the following criteria: australian domiciled company we invest in technology companies from many sectors, but we are particularly interested in companies from the following sectors: healthcare, education, mobile, media, cloud computing and data, security and privacy, machine learning, software, sensors and robotics or food security if a life sciences company, your product should have a strong proof of concept and be at a minimum, in a late stage clinical trial and/or well progressed through the regulatory process if from another sector, your company should be generating sustainable revenue and have a strong market validation approaching profitability with capital required to fuel growth and global expansion if you meet the above criteria, send us a brief document (a 2-page executive summary or introductory powerpoint is sufficient, please do not send larger documents or full information memorandums at this stage) covering at a minimum the following points to entrepreneurs@one-ventures.com: summarize in 2 sentences what your company does (this is important) identify the market, value proposition and your competitive advantage tell us about your progress to date state your revenue for the last financial year and projected revenue for current financial year indicate capital required and how it will be used include 3 point bios of each executive and contact details we will review your proposal and endeavour to revert to you within 2 weeks. for investors investor enquiries: investors@one-ventures.com general enquiries back to the top general enquiries: admin@one-ventures.com telephone: +61 2 8205 7379facsimile: +61 2 9247 9181 //--> sydney oneventures pty ltd level 13 179 elizabeth street sydney nsw 2000 australia brisbane c/- interfinancial level 3, tc beirne building 315 brunswick street fortitude valley qld 4006 australia © 2015 oneventures pty ltd one vision, one team, one purpose disclaimer|contact us


Here you find all texts from your page as Google (googlebot) and others search engines seen it.

Words density analysis:

Numbers of all words: 1484

One word

Two words phrases

Three words phrases

the - 4.58% (68)
and - 3.98% (59)
one - 2.36% (35)
venture - 2.16% (32)
fund - 1.89% (28)
for - 1.68% (25)
invest - 1.68% (25)
oneventures - 1.62% (24)
with - 1.42% (21)
our - 1.28% (19)
are - 1.21% (18)
investment - 1.15% (17)
any - 0.94% (14)
growth - 0.94% (14)
can - 0.88% (13)
you - 0.88% (13)
team - 0.81% (12)
board - 0.81% (12)
companies - 0.74% (11)
all - 0.74% (11)
company - 0.67% (10)
your - 0.67% (10)
find-me - 0.61% (9)
australia - 0.61% (9)
partner - 0.54% (8)
award - 0.54% (8)
innovation - 0.54% (8)
capital - 0.54% (8)
technology - 0.54% (8)
full - 0.47% (7)
high - 0.47% (7)
this - 0.47% (7)
stage - 0.47% (7)
global - 0.47% (7)
adam - 0.47% (7)
directors - 0.4% (6)
point - 0.4% (6)
new - 0.4% (6)
management - 0.4% (6)
carers - 0.4% (6)
has - 0.4% (6)
experience - 0.4% (6)
investor - 0.4% (6)
wearable - 0.4% (6)
sector - 0.4% (6)
that - 0.4% (6)
story - 0.4% (6)
investments - 0.34% (5)
manager - 0.34% (5)
financial - 0.34% (5)
work - 0.34% (5)
technologies - 0.34% (5)
year - 0.34% (5)
market - 0.34% (5)
(fund - 0.34% (5)
media - 0.34% (5)
from - 0.34% (5)
2014 - 0.34% (5)
2013 - 0.34% (5)
about - 0.34% (5)
focus - 0.34% (5)
contact - 0.34% (5)
partners - 0.34% (5)
have - 0.34% (5)
australian - 0.34% (5)
awards - 0.34% (5)
business - 0.34% (5)
portfolio - 0.34% (5)
funds - 0.27% (4)
funding - 0.27% (4)
mobile - 0.27% (4)
executive - 0.27% (4)
late - 0.27% (4)
investors - 0.27% (4)
found - 0.27% (4)
2016 - 0.27% (4)
phone - 0.27% (4)
healthcare - 0.27% (4)
news - 0.27% (4)
will - 0.27% (4)
provide - 0.27% (4)
significant - 0.27% (4)
then - 0.27% (4)
pty - 0.27% (4)
ltd - 0.27% (4)
strong - 0.27% (4)
used - 0.2% (3)
but - 0.2% (3)
read - 0.2% (3)
those - 0.2% (3)
entrepreneurs - 0.2% (3)
information - 0.2% (3)
put - 0.2% (3)
interested - 0.2% (3)
identify - 0.2% (3)
particular - 0.2% (3)
other - 0.2% (3)
not - 0.2% (3)
2015 - 0.2% (3)
meet - 0.2% (3)
incoming - 0.2% (3)
oct - 0.2% (3)
test - 0.2% (3)
clinical - 0.2% (3)
which - 0.2% (3)
rapid - 0.2% (3)
firm - 0.2% (3)
track - 0.2% (3)
opportunities - 0.2% (3)
enquiries - 0.2% (3)
limited - 0.2% (3)
should - 0.2% (3)
following - 0.2% (3)
revenue - 0.2% (3)
under - 0.2% (3)
sydney - 0.2% (3)
more - 0.2% (3)
markets - 0.2% (3)
programme - 0.2% (3)
level - 0.2% (3)
now - 0.2% (3)
back - 0.2% (3)
managing - 0.2% (3)
its - 0.2% (3)
live - 0.2% (3)
value - 0.2% (3)
large - 0.2% (3)
than - 0.2% (3)
around - 0.13% (2)
product - 0.13% (2)
provides - 0.13% (2)
worn - 0.13% (2)
phone, - 0.13% (2)
support - 0.13% (2)
through - 0.13% (2)
system - 0.13% (2)
monitor - 0.13% (2)
including - 0.13% (2)
alert - 0.13% (2)
into - 0.13% (2)
networks. - 0.13% (2)
beyond - 0.13% (2)
dec - 0.13% (2)
points - 0.13% (2)
nsw - 0.13% (2)
street - 0.13% (2)
+61 - 0.13% (2)
general - 0.13% (2)
enquiries: - 0.13% (2)
each - 0.13% (2)
bios - 0.13% (2)
how - 0.13% (2)
current - 0.13% (2)
progress - 0.13% (2)
tell - 0.13% (2)
minimum - 0.13% (2)
data - 0.13% (2)
document - 0.13% (2)
send - 0.13% (2)
required - 0.13% (2)
security - 0.13% (2)
working - 0.13% (2)
series - 0.13% (2)
sep - 0.13% (2)
sciences - 0.13% (2)
life - 0.13% (2)
genomics - 0.13% (2)
19, - 0.13% (2)
cancer - 0.13% (2)
help - 0.13% (2)
dementia, - 0.13% (2)
look - 0.13% (2)
some - 0.13% (2)
investors. - 0.13% (2)
ii) - 0.13% (2)
march - 0.13% (2)
target - 0.13% (2)
partnership - 0.13% (2)
focusing - 0.13% (2)
screening - 0.13% (2)
net-worth - 0.13% (2)
where - 0.13% (2)
$170m - 0.13% (2)
join - 0.13% (2)
innovative - 0.13% (2)
leading - 0.13% (2)
what - 0.13% (2)
wholesale - 0.13% (2)
$20m - 0.13% (2)
page - 0.13% (2)
anne-marie - 0.13% (2)
afsl - 0.13% (2)
corporate - 0.13% (2)
course - 0.13% (2)
many - 0.13% (2)
years - 0.13% (2)
record - 0.13% (2)
birkill - 0.13% (2)
launched - 0.13% (2)
graeme - 0.13% (2)
wald - 0.13% (2)
office - 0.13% (2)
companies. - 0.13% (2)
expansion - 0.13% (2)
early - 0.13% (2)
was - 0.13% (2)
application - 0.13% (2)
stakeholders - 0.13% (2)
find-me. - 0.13% (2)
degrees - 0.13% (2)
diagnosed - 0.13% (2)
extensive - 0.13% (2)
appointment - 0.13% (2)
kossak - 0.13% (2)
senior - 0.13% (2)
medical - 0.13% (2)
law - 0.13% (2)
transformative - 0.13% (2)
medicine - 0.13% (2)
ability - 0.13% (2)
apply - 0.13% (2)
date - 0.13% (2)
legal - 0.13% (2)
commercial - 0.13% (2)
said, - 0.13% (2)
elderly - 0.13% (2)
2017 - 0.13% (2)
smart - 0.13% (2)
nominee - 0.13% (2)
sparrow - 0.13% (2)
vaxxas - 0.13% (2)
world - 0.13% (2)
markets. - 0.13% (2)
may - 0.13% (2)
emerging - 0.13% (2)
ground - 0.13% (2)
20, - 0.13% (2)
learning - 0.13% (2)
see - 0.13% (2)
focused - 0.13% (2)
particularly - 0.13% (2)
strengthens - 0.13% (2)
readiness - 0.13% (2)
feb - 0.13% (2)
visa - 0.13% (2)
the board - 0.47% (7)
board of - 0.4% (6)
fund ii - 0.4% (6)
of the - 0.4% (6)
in the - 0.4% (6)
full story - 0.4% (6)
the oneventures - 0.4% (6)
fund (fund - 0.34% (5)
oneventures innovation - 0.34% (5)
growth fund - 0.34% (5)
of directors - 0.34% (5)
to the - 0.34% (5)
venture capital - 0.34% (5)
carers wearable - 0.34% (5)
we are - 0.27% (4)
and growth - 0.27% (4)
your company - 0.27% (4)
2016 full - 0.27% (4)
innovation fund - 0.27% (4)
pty ltd - 0.27% (4)
find-me technologies - 0.27% (4)
contact us - 0.27% (4)
innovation and - 0.27% (4)
with a - 0.27% (4)
for rapid - 0.2% (3)
rapid growth - 0.2% (3)
the following - 0.2% (3)
a strong - 0.2% (3)
(fund i) - 0.2% (3)
interested in - 0.2% (3)
oneventures board - 0.2% (3)
global markets - 0.2% (3)
us about - 0.2% (3)
news contact - 0.2% (3)
managing partner - 0.2% (3)
around the - 0.13% (2)
to working - 0.13% (2)
mobile phone, - 0.13% (2)
on the - 0.13% (2)
be worn - 0.13% (2)
that can - 0.13% (2)
the carers - 0.13% (2)
of find-me. - 0.13% (2)
to help - 0.13% (2)
more than - 0.13% (2)
oneventures is - 0.13% (2)
partners have - 0.13% (2)
to join - 0.13% (2)
in technology - 0.13% (2)
high growth - 0.13% (2)
anne-marie birkill - 0.13% (2)
find-me carers - 0.13% (2)
awards news - 0.13% (2)
technologies strengthens - 0.13% (2)
companies from - 0.13% (2)
capital required - 0.13% (2)
financial year - 0.13% (2)
revenue for - 0.13% (2)
to date - 0.13% (2)
a minimum - 0.13% (2)
company should - 0.13% (2)
portfolio awards - 0.13% (2)
which is - 0.13% (2)
in readiness - 0.13% (2)
see all - 0.13% (2)
graeme wald - 0.13% (2)
19, 2016 - 0.13% (2)
oct 19, - 0.13% (2)
us team - 0.13% (2)
funds portfolio - 0.13% (2)
20, 2017 - 0.13% (2)
technology companies. - 0.13% (2)
global markets. - 0.13% (2)
adam kossak - 0.13% (2)
a track - 0.13% (2)
if you - 0.13% (2)
oneventures management - 0.13% (2)
this is - 0.13% (2)
focusing on - 0.13% (2)
wholesale investors. - 0.13% (2)
high net-worth - 0.13% (2)
limited partnership - 0.13% (2)
launched in - 0.13% (2)
for funding - 0.13% (2)
fund was - 0.13% (2)
net-worth wholesale - 0.13% (2)
with the - 0.13% (2)
was launched - 0.13% (2)
this fund - 0.13% (2)
early stage - 0.13% (2)
networks. the - 0.13% (2)
i) the - 0.13% (2)
our application - 0.13% (2)
information for - 0.13% (2)
with dementia, - 0.13% (2)
incoming media - 0.13% (2)
those diagnosed - 0.13% (2)
feb 20, - 0.13% (2)
the firm - 0.13% (2)
readiness for - 0.13% (2)
board in - 0.13% (2)
strengthens the - 0.13% (2)
ii which - 0.13% (2)
i) other - 0.13% (2)
stakeholders interested - 0.13% (2)
and networks. - 0.13% (2)
companies with - 0.13% (2)
investment visa - 0.13% (2)
the significant - 0.13% (2)
team funds - 0.13% (2)
for stakeholders - 0.13% (2)
significant investment - 0.13% (2)
the manager - 0.13% (2)
about us - 0.13% (2)
board of directors - 0.34% (5)
and growth fund - 0.27% (4)
2016 full story - 0.27% (4)
innovation and growth - 0.27% (4)
news contact us - 0.2% (3)
for rapid growth - 0.2% (3)
innovation fund (fund - 0.2% (3)
oneventures innovation fund - 0.2% (3)
fund (fund i) - 0.2% (3)
about us team - 0.13% (2)
growth fund (fund - 0.13% (2)
strengthens the board - 0.13% (2)
in readiness for - 0.13% (2)
rapid growth by - 0.13% (2)
feb 20, 2017 - 0.13% (2)
the carers wearable - 0.13% (2)
to the board - 0.13% (2)
those diagnosed with - 0.13% (2)
can be worn - 0.13% (2)
technologies strengthens the - 0.13% (2)
board in readiness - 0.13% (2)
at a minimum - 0.13% (2)
oneventures innovation and - 0.13% (2)
interested in the - 0.13% (2)
significant investment visa - 0.13% (2)
net-worth wholesale investors. - 0.13% (2)
ii which is - 0.13% (2)
and networks. the - 0.13% (2)
networks. the oneventures - 0.13% (2)
i) the oneventures - 0.13% (2)
stage venture capital - 0.13% (2)
fund was launched - 0.13% (2)
fund (fund ii) - 0.13% (2)
funds portfolio awards - 0.13% (2)
the oneventures innovation - 0.13% (2)
was launched in - 0.13% (2)
early stage venture - 0.13% (2)
capital limited partnership - 0.13% (2)
stakeholders interested in - 0.13% (2)
the significant investment - 0.13% (2)
information for stakeholders - 0.13% (2)
oneventures pty ltd - 0.13% (2)

Here you can find chart of all your popular one, two and three word phrases. Google and others search engines means your page is about words you use frequently.

Copyright © 2015-2016 hupso.pl. All rights reserved. FB | +G | Twitter

Hupso.pl jest serwisem internetowym, w którym jednym kliknieciem możesz szybko i łatwo sprawdź stronę www pod kątem SEO. Oferujemy darmowe pozycjonowanie stron internetowych oraz wycena domen i stron internetowych. Prowadzimy ranking polskich stron internetowych oraz ranking stron alexa.